BA
NVO

Ballast Advisors’s Novo Nordisk NVO Stock Holding History

Ballast Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$942K Sell
19,653
-1,895
-9% -$81.4K 0.22% 52
2026
Q1 		$792K Buy
21,548
+189
+0.9% +$8.96K 0.23% 53
2025
Q4 		$1.09M Sell
21,359
-376
-2% -$19.2K 0.3% 47
2025
Q3 		$1.21M Sell
21,735
-158
-0.7% -$9.25K 0.33% 46
2025
Q2 		$1.51M Buy
21,893
+1,500
+7% +$102K 0.45% 35
2025
Q1 		$1.42M Buy
20,393
+1,938
+11% +$160K 0.45% 34
2024
Q4 		$1.59M Buy
18,455
+1,771
+11% +$192K 0.49% 33
2024
Q3 		$1.99M Sell
16,684
-560
-3% -$74.7K 0.61% 27
2024
Q2 		$2.46M Buy
17,244
+866
+5% +$115K 0.78% 22
2024
Q1 		$2.1M Buy
16,378
+488
+3% +$58.1K 0.71% 22
2023
Q4 		$1.64M Buy
15,890
+3,478
+28% +$344K 0.61% 25
2023
Q3 		$1.13M Buy
12,412
+7,168
+137% +$631K 0.45% 31
2023
Q2 		$424K Buy
5,244
+1,842
+54% +$150K 0.16% 69
2023
Q1 		$271K Buy
+3,402
New +$241K 0.11% 92

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Ballast Advisors's NVO Position: Q2 2026 in Review

Ballast Advisors reduced its Novo Nordisk (NVO) stake by 8.8% in Q2 2026, selling an estimated $81.4K and leaving 19,653 shares worth $942K. The position accounts for 0.22% of the portfolio, ranked #52.

Ballast Advisors first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.46M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Ballast Advisors held 19,653 shares of Novo Nordisk worth $942K as of Q2 2026.
  • Ballast Advisors sold 1,895 Novo Nordisk shares in Q2 2026, an estimated $81.4K.
  • Novo Nordisk made up 0.22% of Ballast Advisors's portfolio in Q2 2026, its #52 holding.
  • Ballast Advisors first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
  • Ballast Advisors's Novo Nordisk position peaked at $2.46M in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Ballast Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.